{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:13:19Z","timestamp":1792548799609,"version":"4.5.0"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09089-4","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T16:55:03Z","timestamp":1754585703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Systemic Psoriasis: From Molecular Mechanisms to Global Management Strategies"],"prefix":"10.1007","volume":"68","author":[{"given":"Suriyaraj Shanmugasundaram","family":"Prema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepankumar","family":"Shanmugamprema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"11","key":"9089_CR1","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/biomedicines9111511","volume":"9","author":"A Campanati","year":"2021","unstructured":"Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A (2021) Psoriasis as an immune-mediated and inflammatory systemic disease: from pathophysiology to novel therapeutic approaches. Biomedicines 9(11):1511. https:\/\/doi.org\/10.3390\/biomedicines9111511","journal-title":"Biomedicines"},{"issue":"9","key":"9089_CR2","doi-asserted-by":"publisher","first-page":"e29536","DOI":"10.7759\/cureus.29536","volume":"14","author":"A Dhabale","year":"2022","unstructured":"Dhabale A, Nagpure S (2022) Types of psoriasis and their effects on the immune system. Cureus 14(9):e29536. https:\/\/doi.org\/10.7759\/cureus.29536","journal-title":"Cureus"},{"issue":"8","key":"9089_CR3","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/jdv.16273","volume":"34","author":"A Egeberg","year":"2020","unstructured":"Egeberg A, Gisondi P, Carrascosa JM, Warren RB, Mrowietz U (2020) The role of the interleukin-23\/Th17 pathway in cardiometabolic comorbidity associated with psoriasis. J Eur Acad Dermatol Venereol 34(8):1695\u20131706","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 4","key":"9089_CR4","doi-asserted-by":"publisher","first-page":"iv16","DOI":"10.1093\/rheumatology\/keab385","volume":"60","author":"Z \u0141ukasik","year":"2021","unstructured":"\u0141ukasik Z, Gracey E, Venken K, Ritchlin C, Elewaut D (2021) Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and joints. Rheumatology 60(Suppl 4):iv16\u2013iv27","journal-title":"Rheumatology"},{"key":"9089_CR5","doi-asserted-by":"publisher","first-page":"743180","DOI":"10.3389\/fmed.2021.743180","volume":"8","author":"G Damiani","year":"2021","unstructured":"Damiani G, Bragazzi NL, Karimkhani Aksut C et al (2021) The global, regional, and national burden of psoriasis: results and insights from the Global Burden of Disease 2019 Study. Front Med (Lausanne) 8:743180. https:\/\/doi.org\/10.3389\/fmed.2021.743180","journal-title":"Front Med (Lausanne)"},{"key":"9089_CR6","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","volume":"369","author":"Rosa Parisi","year":"2020","unstructured":"Parisi Rosa et al (2020) National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ (Clinical research ed.) 369:m1590. https:\/\/doi.org\/10.1136\/bmj.m1590","journal-title":"BMJ (Clinical research ed.)"},{"issue":"5","key":"9089_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5114\/reum.2022.120752","volume":"60","author":"W Owczarek","year":"2022","unstructured":"Owczarek W (2022) The role of HLA-Cw6 in psoriasis and psoriatic arthritis. Reumatologia 60(5):303\u2013305. https:\/\/doi.org\/10.5114\/reum.2022.120752","journal-title":"Reumatologia"},{"issue":"15","key":"9089_CR8","doi-asserted-by":"publisher","first-page":"12310","DOI":"10.3390\/ijms241512310","volume":"24","author":"HA Patel","year":"2023","unstructured":"Patel HA, Revankar RR, Pedroza ST, Graham S, Feldman SR (2023) The genetic susceptibility to psoriasis and the relationship of linked genes to our treatment options. Int J Mol Sci 24(15):12310. https:\/\/doi.org\/10.3390\/ijms241512310","journal-title":"Int J Mol Sci"},{"issue":"2","key":"9089_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM (2024) The immunology of psoriasis\u2013current concepts in pathogenesis. Clin Rev Allergy Immunol 66(2):164\u2013191. https:\/\/doi.org\/10.1007\/s12016-024-08991-7","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"9089_CR10","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/bab.2619","volume":"71","author":"RK Sharma","year":"2024","unstructured":"Sharma RK, Sharma MR, Mahendra A, Singh S, Sood S, Upadhyay SK, Sharma AK (2024) Hyposalivation in patients with psoriasis: association with severity, inflammatory, and anti-inflammatory cytokine biomarkers of the disease. Biotechnol Appl Biochem 71(5):1170\u20131180. https:\/\/doi.org\/10.1002\/bab.2619","journal-title":"Biotechnol Appl Biochem"},{"issue":"2","key":"9089_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s13555-021-00483-2","volume":"11","author":"A Menter","year":"2021","unstructured":"Menter A, Krueger GG, Paek SY, Kivelevitch D, Adamopoulos IE, Langley RG (2021) Interleukin-17 and interleukin-23: a narrative review of mechanisms of action in psoriasis and associated comorbidities. Dermatol Ther (Heidelb) 11(2):385\u2013400","journal-title":"Dermatol Ther (Heidelb)"},{"key":"9089_CR12","doi-asserted-by":"publisher","first-page":"1824624","DOI":"10.1155\/2019\/1824624","volume":"2019","author":"L Sun","year":"2019","unstructured":"Sun L, Liu W, Zhang LJ (2019) The role of toll-like receptors in skin host defense, psoriasis, and atopic dermatitis. J Immunol Res 2019:1824624","journal-title":"J Immunol Res"},{"key":"9089_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X et al (2024) NF-\u03bab in biology and targeted therapy: new insights and translational implications. Sig Transduct Target Ther 9:53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"9089_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Chen Y, Cui L, Shi Y, Guo C (2022) Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis 13(1):81. https:\/\/doi.org\/10.1038\/s41419-022-04523-3","journal-title":"Cell Death Dis"},{"key":"9089_CR15","doi-asserted-by":"publisher","unstructured":"Yamuna K, Dwarampudi P, Shanmugam R, Mirunalini G, Dutta S, Nagaraj N, Ramaswamy K (2025) A review on phytoconstituents for the management of psoriasis. Nat Prod Commun 20. https:\/\/doi.org\/10.1177\/1934578X251342473","DOI":"10.1177\/1934578X251342473"},{"issue":"12","key":"9089_CR16","doi-asserted-by":"publisher","first-page":"BSR20193266","DOI":"10.1042\/BSR20193266","volume":"39","author":"YZ Ji","year":"2019","unstructured":"Ji YZ, Liu SR (2019) Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms. Biosci Rep 39(12):BSR20193266. https:\/\/doi.org\/10.1042\/BSR20193266","journal-title":"Biosci Rep"},{"issue":"3","key":"9089_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM (2017) Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol 76(3):377\u2013390. https:\/\/doi.org\/10.1016\/j.jaad.2016.07.064","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"9089_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/ijms26020749","volume":"26","author":"OA Orzan","year":"2025","unstructured":"Orzan OA, Tutunaru CV, Iano\u0219i SL (2025) Understanding the intricate pathophysiology of psoriasis and related skin disorders. Int J Mol Sci 26(2):749. https:\/\/doi.org\/10.3390\/ijms26020749","journal-title":"Int J Mol Sci"},{"key":"9089_CR19","unstructured":"Banday S, Kakroo B, Beg MA (2024) Association between psoriasis and cardiovascular diseases. Eur J Cardiovasc Med 14(5)"},{"issue":"8","key":"9089_CR20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/cells14080610","volume":"14","author":"A Bielach-Bazyluk","year":"2025","unstructured":"Bielach-Bazyluk A, Bossowski F, Skorupska M, Mysliwiec H, Bossowski AT, Flisiak I (2025) Psoriasis in obese adolescents with diabetes from common molecular background to vicious circle of metabolic syndrome case report and review of literature. Cells 14(8):610. https:\/\/doi.org\/10.3390\/cells14080610","journal-title":"Cells"},{"issue":"Pt 1","key":"9089_CR21","doi-asserted-by":"publisher","first-page":"113388","DOI":"10.1016\/j.intimp.2024.113388","volume":"143","author":"F Ferrara","year":"2024","unstructured":"Ferrara F, Verduci C, Laconi E, Mangione A, Dondi C, Del Vecchio M, Carlevatti V, Zovi A, Capuozzo M, Langella R (2024) Current therapeutic overview and future perspectives regarding the treatment of psoriasis. Int Immunopharmacol 143(Pt 1):113388. https:\/\/doi.org\/10.1016\/j.intimp.2024.113388","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"9089_CR22","doi-asserted-by":"publisher","first-page":"adv00032","DOI":"10.2340\/00015555-3386","volume":"100","author":"C Reid","year":"2020","unstructured":"Reid C, Griffiths CEM (2020) Psoriasis and treatment: past, present and future aspects. Acta Derm Venereol 100(3):adv00032. https:\/\/doi.org\/10.2340\/00015555-3386","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"9089_CR23","doi-asserted-by":"publisher","first-page":"e12946","DOI":"10.1111\/sji.12946","volume":"92","author":"LL Ten Bergen","year":"2020","unstructured":"Ten Bergen LL, Petrovic A, Krogh Aarebrot A, Appel S (2020) The TNF\/IL-23\/IL-17 axis\u2013head-to-head trials comparing different biologics in psoriasis treatment. Scand J Immunol 92(4):e12946. https:\/\/doi.org\/10.1111\/sji.12946","journal-title":"Scand J Immunol"},{"key":"9089_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2147\/CCID.S462797","volume":"17","author":"L Potestio","year":"2024","unstructured":"Potestio L, Martora F, Lauletta G, Vallone Y, Battista T, Megna M (2024) The role of interleukin 23\/17 axis in psoriasis management: a comprehensive review of clinical trials. Clin Cosmet Investig Dermatol 17:829\u2013842. https:\/\/doi.org\/10.2147\/CCID.S462797","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"9089_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4103\/ijd.ijd_166_24","volume":"69","author":"VC Konakanchi","year":"2024","unstructured":"Konakanchi VC, Kar BR, Sathishkumar D et al (2024) Small molecules in the management of psoriasis and psoriatic arthritis. Indian J Dermatol 69(3):249\u2013255. https:\/\/doi.org\/10.4103\/ijd.ijd_166_24","journal-title":"Indian J Dermatol"},{"key":"9089_CR26","doi-asserted-by":"crossref","unstructured":"Gosia M, Doshi G, Parab SB, Godad A (2025) Innovative approaches to psoriasis: small molecules targeting key signaling pathways. Immunol Investig 1\u201337","DOI":"10.1080\/08820139.2025.2449960"},{"key":"9089_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/PTT.S328572","volume":"12","author":"C Daugaard","year":"2022","unstructured":"Daugaard C, Iversen L, Hjuler KF (2022) Comorbidity in adult psoriasis: considerations for the clinician. Psoriasis (Auckl) 12:139\u2013150. https:\/\/doi.org\/10.2147\/PTT.S328572","journal-title":"Psoriasis (Auckl)"},{"key":"9089_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/PTT.S328447","volume":"12","author":"B Blackstone","year":"2022","unstructured":"Blackstone B, Patel R, Bewley A (2022) Assessing and improving psychological well-being in psoriasis: considerations for the clinician. Psoriasis (Auckl) 12:25\u201333. https:\/\/doi.org\/10.2147\/PTT.S328447","journal-title":"Psoriasis (Auckl)"},{"issue":"13","key":"9089_CR29","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.3390\/ijms25137349","volume":"25","author":"S Rossi","year":"2024","unstructured":"Rossi S, Richards EL, Orozco G, Eyre S (2024) Functional genomics in psoriasis. Int J Mol Sci 25(13):7349. https:\/\/doi.org\/10.3390\/ijms25137349","journal-title":"Int J Mol Sci"},{"issue":"7","key":"9089_CR30","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.3390\/ijms25073831","volume":"25","author":"J Olejnik-Wojciechowska","year":"2024","unstructured":"Olejnik-Wojciechowska J, Boboryko D, Bratborska AW, Rusi\u0144ska K, Ostrowski P, Baranowska M, Pawlik A (2024) The role of epigenetic factors in the pathogenesis of psoriasis. Int J Mol Sci 25(7):3831. https:\/\/doi.org\/10.3390\/ijms25073831","journal-title":"Int J Mol Sci"},{"key":"9089_CR31","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.3389\/fimmu.2018.02239","volume":"9","author":"L Israel","year":"2018","unstructured":"Israel L, Mellett M (2018) Clinical and genetic heterogeneity of CARD14 mutations in psoriatic skin disease. Front Immunol 9:2239. https:\/\/doi.org\/10.3389\/fimmu.2018.02239","journal-title":"Front Immunol"},{"issue":"2","key":"9089_CR32","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3390\/ijms25021042","volume":"25","author":"L Rusi\u00f1ol","year":"2024","unstructured":"Rusi\u00f1ol L, Puig L (2024) Multi-omics approach to improved diagnosis and treatment of atopic dermatitis and psoriasis. Int J Mol Sci 25(2):1042. https:\/\/doi.org\/10.3390\/ijms25021042","journal-title":"Int J Mol Sci"},{"key":"9089_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-025-06099-w","volume":"23","author":"H Guo","year":"2025","unstructured":"Guo H, Gao J, Gong L et al (2025) Multi-omics analysis reveals novel causal pathways in psoriasis pathogenesis. J Transl Med 23:100. https:\/\/doi.org\/10.1186\/s12967-025-06099-w","journal-title":"J Transl Med"},{"key":"9089_CR34","doi-asserted-by":"publisher","unstructured":"Balendran N, Clough RL, Arguello JR, Barber R, Veal C, Jones AB, Rosbotham JL, Little AM, Madrigal A, Barker JN, Powis SH, Trembath RC (1999) Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Investig Dermatol 113(3):322\u2013328. https:\/\/doi.org\/10.1046\/j.1523-1747.1999.00710.x","DOI":"10.1046\/j.1523-1747.1999.00710.x"},{"key":"9089_CR35","doi-asserted-by":"publisher","first-page":"1141010","DOI":"10.3389\/fgene.2023.1141010","volume":"14","author":"A Bui","year":"2023","unstructured":"Bui A, Kumar S, Liu J et al (2023) A partitioned 88-loci psoriasis genetic risk score reveals HLA and non-HLA contributions to clinical phenotypes in a Newfoundland psoriasis cohort. Front Genet 14:1141010. https:\/\/doi.org\/10.3389\/fgene.2023.1141010","journal-title":"Front Genet"},{"key":"9089_CR36","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1038\/s41467-025-56719-8","volume":"16","author":"N Dand","year":"2025","unstructured":"Dand N, Stuart PE, Bowes J et al (2025) GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets. Nat Commun 16:2051. https:\/\/doi.org\/10.1038\/s41467-025-56719-8","journal-title":"Nat Commun"},{"key":"9089_CR37","doi-asserted-by":"publisher","unstructured":"Strange A, Capon F et al (2010) Genetic analysis of psoriasis consortium & the wellcome trust case control consortium 2. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42(11):985\u2013990. https:\/\/doi.org\/10.1038\/ng.694","DOI":"10.1038\/ng.694"},{"issue":"7","key":"9089_CR38","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.3390\/ijms26072895","volume":"26","author":"D Simancas-Racines","year":"2025","unstructured":"Simancas-Racines D, Rom\u00e1n-Galeano NM, Verde L, Annunziata G, Marchetti M, Matos A, Campuzano-Donoso M, Reytor-Gonz\u00e1lez C, Muscogiuri G, Barrea L et al (2025) Targeting cytokine dysregulation in psoriasis: the role of dietary interventions in modulating the immune response. Int J Mol Sci 26(7):2895. https:\/\/doi.org\/10.3390\/ijms26072895","journal-title":"Int J Mol Sci"},{"issue":"4","key":"9089_CR39","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/bjd.12442","volume":"169","author":"XY Yin","year":"2013","unstructured":"Yin XY, Zhang R, Cheng H, Pan Q, Shen CB, Fan X, Wang ZX, Sun LD, Yang S, Zhang XJ (2013) Gene-gene interactions between HLA-C, ERAP1, TNFAIP3 and TRAF3IP2 and the risk of psoriasis in the Chinese Han population. Br J Dermatol 169(4):941\u2013943. https:\/\/doi.org\/10.1111\/bjd.12442","journal-title":"Br J Dermatol"},{"issue":"9","key":"9089_CR40","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.jid.2018.03.1525","volume":"138","author":"M Mellett","year":"2018","unstructured":"Mellett M, Meier B, Mohanan D, Schairer R, Cheng P, Satoh TK, Kiefer B, Ospelt C, Nobbe S, Thome M, Contassot E, French LE (2018) CARD14 gain-of-function mutation alone is sufficient to drive IL-23\/IL-17-mediated psoriasiform skin inflammation in vivo. J Invest Dermatol 138(9):2010\u20132023. https:\/\/doi.org\/10.1016\/j.jid.2018.03.1525","journal-title":"J Invest Dermatol"},{"issue":"1","key":"9089_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.immuni.2018.05.012","volume":"49","author":"M Wang","year":"2018","unstructured":"Wang M, Zhang S, Zheng G, Huang J, Songyang Z, Zhao X, Lin X (2018) Gain-of-function mutation of Card14 leads to spontaneous psoriasis-like skin inflammation through enhanced keratinocyte response to IL-17A. Immunity 49(1):66-79.e5. https:\/\/doi.org\/10.1016\/j.immuni.2018.05.012","journal-title":"Immunity"},{"issue":"1","key":"9089_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00281-021-00901-9","volume":"44","author":"T Naito","year":"2022","unstructured":"Naito T, Okada Y (2022) HLA imputation and its application to genetic and molecular fine-mapping of the MHC region in autoimmune diseases. Semin Immunopathol 44(1):15\u201328. https:\/\/doi.org\/10.1007\/s00281-021-00901-9","journal-title":"Semin Immunopathol"},{"issue":"8","key":"9089_CR43","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3390\/genes14081619","volume":"14","author":"L Mateu-Arrom","year":"2023","unstructured":"Mateu-Arrom L, Puig L (2023) Genetic and epigenetic mechanisms of psoriasis. Genes 14(8):1619. https:\/\/doi.org\/10.3390\/genes14081619","journal-title":"Genes"},{"issue":"1","key":"9089_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","volume":"38","author":"SK Mahil","year":"2016","unstructured":"Mahil SK, Capon F, Barker JN (2016) Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol 38(1):11\u201327. https:\/\/doi.org\/10.1007\/s00281-015-0539-8","journal-title":"Semin Immunopathol"},{"key":"9089_CR45","doi-asserted-by":"publisher","unstructured":"Salleh MN, Ramachandran V, Lai H, Aminah S (2025) Detection of JunB and C-FLIP psoriasis genes using the reverse transcriptase in-situ PCR technique. Biomed Sci Clin Med 64:1\u20139. https:\/\/doi.org\/10.12982\/BSCM.2025.08","DOI":"10.12982\/BSCM.2025.08"},{"issue":"9","key":"9089_CR46","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.4049\/jimmunol.2100686","volume":"207","author":"A Arakawa","year":"2021","unstructured":"Arakawa A, Reeves E, Vollmer S et al (2021) ERAP1 controls the autoimmune response against melanocytes in psoriasis by generating the melanocyte autoantigen and regulating its amount for HLA-C*06:02 presentation. J Immunol 207(9):2235\u20132244. https:\/\/doi.org\/10.4049\/jimmunol.2100686","journal-title":"J Immunol"},{"issue":"6","key":"9089_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/intimm\/dxx035","volume":"29","author":"DPW Rastall","year":"2017","unstructured":"Rastall DPW, Alyaquob FS, O\u2019Connell P et al (2017) Mice expressing human ERAP1 variants associated with ankylosing spondylitis have altered T-cell repertoires and NK cell functions, as well as increased in utero and perinatal mortality. Int Immunol 29(6):277\u2013289. https:\/\/doi.org\/10.1093\/intimm\/dxx035","journal-title":"Int Immunol"},{"key":"9089_CR48","doi-asserted-by":"publisher","first-page":"1490051","DOI":"10.3389\/fimmu.2024.1490051","volume":"15","author":"MR Nielsen","year":"2025","unstructured":"Nielsen MR, Skougaard M, Drachmann C, Stisen ZR, Ditlev SB, Jessen LE, Kristensen LE (2025) Single-cell RNA sequencing highlights the influence of innate and adaptive immune response mechanisms in psoriatic arthritis. Front Immunol 15:1490051. https:\/\/doi.org\/10.3389\/fimmu.2024.1490051","journal-title":"Front Immunol"},{"issue":"17","key":"9089_CR49","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.3390\/ijms22179294","volume":"22","author":"K Dopytalska","year":"2021","unstructured":"Dopytalska K, Ciechanowicz P, Wiszniewski K, Szyma\u0144ska E, Walecka I (2021) The role of epigenetic factors in psoriasis. Int J Mol Sci 22(17):9294. https:\/\/doi.org\/10.3390\/ijms22179294","journal-title":"Int J Mol Sci"},{"issue":"19","key":"9089_CR50","doi-asserted-by":"publisher","first-page":"14551","DOI":"10.3390\/ijms241914551","volume":"24","author":"D Romh\u00e1nyi","year":"2023","unstructured":"Romh\u00e1nyi D, Szab\u00f3 K, Kem\u00e9ny L, Groma G (2023) Histone and histone acetylation-related alterations of gene expression in uninvolved psoriatic skin and their effects on cell proliferation, differentiation, and immune responses. Int J Mol Sci 24(19):14551. https:\/\/doi.org\/10.3390\/ijms241914551","journal-title":"Int J Mol Sci"},{"issue":"5","key":"9089_CR51","doi-asserted-by":"publisher","first-page":"e0217352","DOI":"10.1371\/journal.pone.0217352","volume":"14","author":"NY Sahlol","year":"2019","unstructured":"Sahlol NY, Mostafa MS, Madkour LAE, Salama DM (2019) Low TNFAIP3 expression in psoriatic skin promotes disease susceptibility and severity. PLoS One 14(5):e0217352. https:\/\/doi.org\/10.1371\/journal.pone.0217352","journal-title":"PLoS One"},{"key":"9089_CR52","doi-asserted-by":"publisher","first-page":"5980190","DOI":"10.1155\/2020\/5980190","volume":"2020","author":"Yanyun Jiang","year":"2020","unstructured":"Jiang Yanyun, Wang Wenming, Zheng Xiaofeng, Jin Hongzhong (2020) Immune regulation of TNFAIP3 in psoriasis through its association with Th1 and Th17 cell differentiation and p38 activation. J Immunol Res 2020:5980190. https:\/\/doi.org\/10.1155\/2020\/5980190","journal-title":"J Immunol Res"},{"issue":"1","key":"9089_CR53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jid.2018.06.191","volume":"139","author":"M Devos","year":"2019","unstructured":"Devos M, Mogilenko DA, Fleury S, Gilbert B, Becquart C, Quemener S, Dehondt H, Tougaard P, Staels B, Bachert C, Vandenabeele P, Van Loo G, Staumont-Salle D, Declercq W, Dombrowicz D (2019) Keratinocyte expression of A20\/TNFAIP3 controls skin inflammation associated with atopic dermatitis and psoriasis. J Invest Dermatol 139(1):135\u2013145. https:\/\/doi.org\/10.1016\/j.jid.2018.06.191","journal-title":"J Invest Dermatol"},{"issue":"4","key":"9089_CR54","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/CM9.0000000000001243","volume":"134","author":"JK Song","year":"2020","unstructured":"Song JK, Yin SY, Li W et al (2020) An update on the role of long non-coding RNAs in psoriasis. Chin Med J (Engl) 134(4):379\u2013389. https:\/\/doi.org\/10.1097\/CM9.0000000000001243","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"9089_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10142-023-01057-5","volume":"23","author":"D Ghosh","year":"2023","unstructured":"Ghosh D, Ganguly T, Chatterjee R (2023) Emerging roles of non-coding RNAs in psoriasis pathogenesis. Funct Integr Genomics 23(2):129. https:\/\/doi.org\/10.1007\/s10142-023-01057-5","journal-title":"Funct Integr Genomics"},{"key":"9089_CR56","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/exd.14497","volume":"31","author":"\u00c5\u00d8 Solvin","year":"2022","unstructured":"Solvin \u00c5\u00d8, Chawla K, Olsen LC et al (2022) Microrna profiling of psoriatic skin identifies 11 miRNAs associated with disease severity. Exp Dermatol 31:535\u2013547. https:\/\/doi.org\/10.1111\/exd.14497","journal-title":"Exp Dermatol"},{"key":"9089_CR57","doi-asserted-by":"publisher","unstructured":"Xu N, Meisgen F, Butler LM, Han G, Wang XJ, S\u00f6derberg-Naucl\u00e9r C, St\u00e5hle M, Pivarcsi A, Sonkoly E (2013) MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine\/threonine kinase 40. J Immunol 190(2):678\u2013688. https:\/\/doi.org\/10.4049\/jimmunol.1202695","DOI":"10.4049\/jimmunol.1202695"},{"key":"9089_CR58","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/exd.13249","volume":"26","author":"Q Liu","year":"2017","unstructured":"Liu Q, Wu D-H, Han L, Deng J-W, Zhou L, He R, Lu C-J, Mi Q-S (2017) Roles of microRNAs in psoriasis: immunological functions and potential biomarkers. Exp Dermatol 26:359\u2013367. https:\/\/doi.org\/10.1111\/exd.13249","journal-title":"Exp Dermatol"},{"issue":"3","key":"9089_CR59","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1172\/JCI74347","volume":"125","author":"G Murugaiyan","year":"2015","unstructured":"Murugaiyan G, da Cunha AP, Ajay AK, Joller N, Garo LP, Kumaradevan S, Yosef N, Vaidya VS, Weiner HL (2015) MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J Clin Investig 125(3):1069\u20131080. https:\/\/doi.org\/10.1172\/JCI74347","journal-title":"J Clin Investig"},{"issue":"11","key":"9089_CR60","doi-asserted-by":"publisher","first-page":"e112408","DOI":"10.1371\/journal.pone.0112408","volume":"9","author":"K Sato","year":"2014","unstructured":"Sato K, Takaishi M, Tokuoka S, Sano S (2014) Involvement of TNF-\u03b1 converting enzyme in the development of psoriasis-like lesions in a mouse model. PLoS One 9(11):e112408. https:\/\/doi.org\/10.1371\/journal.pone.0112408","journal-title":"PLoS One"},{"issue":"7","key":"9089_CR61","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/jid.2011.55","volume":"131","author":"N Xu","year":"2011","unstructured":"Xu N, Brodin P, Wei T, Meisgen F, Eidsmo L, Nagy N, Kemeny L, St\u00e5hle M, Sonkoly E, Pivarcsi A (2011) MiR-125b, a microrna downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol 131(7):1521\u20131529. https:\/\/doi.org\/10.1038\/jid.2011.55","journal-title":"J Invest Dermatol"},{"issue":"5","key":"9089_CR62","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1365-2133.2011.10497.x","volume":"165","author":"A Ichihara","year":"2011","unstructured":"Ichihara A, Jinnin M, Yamane K, Fujisawa A, Sakai K, Masuguchi S, Fukushima S, Maruo K, Ihn H (2011) Microrna-mediated keratinocyte hyperproliferation in psoriasis vulgaris. Br J Dermatol 165(5):1003\u20131010. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10497.x","journal-title":"Br J Dermatol"},{"issue":"6","key":"9089_CR63","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/exd.13520","volume":"27","author":"M Masalha","year":"2018","unstructured":"Masalha M, Sidi Y, Avni D (2018) The contribution of feedback loops between miRNAs, cytokines and growth factors to the pathogenesis of psoriasis. Exp Dermatol 27(6):603\u2013610. https:\/\/doi.org\/10.1111\/exd.13520","journal-title":"Exp Dermatol"},{"issue":"6","key":"9089_CR64","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JohnS Mattick","year":"2023","unstructured":"Mattick John S et al (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24(6):430\u2013447. https:\/\/doi.org\/10.1038\/s41580-022-00566-8","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"9089_CR65","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/biom12081072","volume":"12","author":"SC Yang","year":"2022","unstructured":"Yang SC, Alalaiwe A, Lin ZC, Lin YC, Aljuffali IA, Fang JY (2022) Anti-inflammatory microRNAs for treating inflammatory skin diseases. Biomolecules 12(8):1072. https:\/\/doi.org\/10.3390\/biom12081072","journal-title":"Biomolecules"},{"issue":"1","key":"9089_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ncrna11010007","volume":"11","author":"K Kie\u0142bowski","year":"2025","unstructured":"Kie\u0142bowski K, J\u0119drasiak A, Bakinowska E, Pawlik A (2025) The role of long non-coding RNA in the pathogenesis of psoriasis. Non-coding RNA 11(1):7. https:\/\/doi.org\/10.3390\/ncrna11010007","journal-title":"Non-coding RNA"},{"issue":"9","key":"9089_CR67","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/jpm12091452","volume":"12","author":"A Reolid","year":"2022","unstructured":"Reolid A, Sahuquillo-Torralba A, Sanz-Garc\u00eda A et al (2022) CNVs associated with different clinical phenotypes of psoriasis and anti-TNF-induced palmoplantar pustulosis. J Pers Med 12(9):1452. https:\/\/doi.org\/10.3390\/jpm12091452","journal-title":"J Pers Med"},{"key":"9089_CR68","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3389\/fimmu.2020.01176","volume":"11","author":"JR Shelley","year":"2020","unstructured":"Shelley JR, Davidson DJ, Dorin JR (2020) The dichotomous responses driven by \u03b2-defensins. Front Immunol 11:1176. https:\/\/doi.org\/10.3389\/fimmu.2020.01176","journal-title":"Front Immunol"},{"key":"9089_CR69","doi-asserted-by":"publisher","unstructured":"Niehues H, van der Krieken DA, Ederveen Thomas THA, Jansen PAM, van Niftrik L, Mesman R, Netea MG, Smits JPH, Schalkwijk J, van den Bogaard EH, Zeeuwen PLJM (2021) Antimicrobial late cornified envelope (LCE) proteins: the psoriasis risk factor LCE3B\/C-del affects microbiota composition. J Invest Dermatol 142. https:\/\/doi.org\/10.1016\/j.jid.2021.11.036","DOI":"10.1016\/j.jid.2021.11.036"},{"issue":"43","key":"9089_CR70","doi-asserted-by":"publisher","first-page":"21666","DOI":"10.1073\/pnas.1909687116","volume":"116","author":"WY Tseng","year":"2019","unstructured":"Tseng WY, Huang YS, Clanchy F, McNamee K, Perocheau D, Ogbechi J, Luo SF, Feldmann M, McCann FE, Williams RO (2019) TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells. Proc Natl Acad Sci USA 116(43):21666\u201321672. https:\/\/doi.org\/10.1073\/pnas.1909687116","journal-title":"Proc Natl Acad Sci USA"},{"key":"9089_CR71","doi-asserted-by":"publisher","unstructured":"Cui L, Wu Y, Chen Z, Li B, Cai J, Chang Z, Xiao W, Wang Y, Yang N, Wang Y, Yu Z, Yao L, Ma R, Wang X, Chen Y, Chen Q, Mei H, Lan Z, Yu Y, Chen R, Shi Y et al (2024) N6-methyladenosine modification-tuned lipid metabolism controls skin immune homeostasis via regulating neutrophil chemotaxis. Sci Adv 10(40):eadp5332. https:\/\/doi.org\/10.1126\/sciadv.adp5332","DOI":"10.1126\/sciadv.adp5332"},{"issue":"1","key":"9089_CR72","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13148-021-01126-1","volume":"13","author":"TH Beacon","year":"2021","unstructured":"Beacon TH, Delcuve GP, L\u00f3pez C, Nardocci G, Kovalchuk I, van Wijnen AJ, Davie JR (2021) The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes. Clin Epigenetics 13(1):138. https:\/\/doi.org\/10.1186\/s13148-021-01126-1","journal-title":"Clin Epigenetics"},{"issue":"21","key":"9089_CR73","doi-asserted-by":"publisher","first-page":"11670","DOI":"10.3390\/ijms252111670","volume":"25","author":"M Nied\u017awied\u017a","year":"2024","unstructured":"Nied\u017awied\u017a M, Skibi\u0144ska M, Ci\u0105\u017cy\u0144ska M, Noweta M, Czerwi\u0144ska A, Krzy\u015bcin J, Narbutt J, Lesiak A (2024) Psoriasis and seasonality: exploring the genetic and epigenetic interactions. Int J Mol Sci 25(21):11670. https:\/\/doi.org\/10.3390\/ijms252111670","journal-title":"Int J Mol Sci"},{"key":"9089_CR74","first-page":"388","volume":"18","author":"B Haritha","year":"2024","unstructured":"Haritha B, Praneetha D, Kondaveeti S, Nikhil B (2024) Impact of environmental exposures and psychosocial stress on psoriasis severity: a cross-sectional study in an adult population. Res J Med Sci 18:388\u2013392","journal-title":"Res J Med Sci"},{"key":"9089_CR75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-5945-9-5","volume":"9","author":"L Mallbris","year":"2009","unstructured":"Mallbris L, Wolk K, S\u00e1nchez F, St\u00e5hle M (2009) HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study. BMC Dermatol 9:5. https:\/\/doi.org\/10.1186\/1471-5945-9-5","journal-title":"BMC Dermatol"},{"key":"9089_CR76","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.2147\/JIR.S506103","volume":"18","author":"M Miao","year":"2025","unstructured":"Miao M, Yan J, Sun Y, Liu J, Guo S (2025) Psoriasis: unraveling disease mechanisms and advancing pharmacological and nanotechnological treatments. J Inflamm Res 18:2045\u20132072. https:\/\/doi.org\/10.2147\/JIR.S506103","journal-title":"J Inflamm Res"},{"issue":"4","key":"9089_CR77","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s12291-010-0043-9","volume":"25","author":"DP Kadam","year":"2010","unstructured":"Kadam DP, Suryakar AN, Ankush RD, Kadam CY, Deshpande KH (2010) Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem 25(4):388\u2013392. https:\/\/doi.org\/10.1007\/s12291-010-0043-9","journal-title":"Indian J Clin Biochem"},{"issue":"1","key":"9089_CR78","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/07853890.2021.2022187","volume":"54","author":"Y Li","year":"2022","unstructured":"Li Y, Cao Z, Guo J et al (2022) Assessment of efficacy and safety of UV-based therapy for psoriasis: a network meta-analysis of randomized controlled trials. Ann Med 54(1):159\u2013169. https:\/\/doi.org\/10.1080\/07853890.2021.2022187","journal-title":"Ann Med"},{"issue":"7","key":"9089_CR79","doi-asserted-by":"publisher","first-page":"e2421665","DOI":"10.1001\/jamanetworkopen.2024.21665","volume":"7","author":"J Wu","year":"2024","unstructured":"Wu J, Ma Y, Yang J, Tian Y (2024) Exposure to air pollution, genetic susceptibility, and psoriasis risk in the UK. JAMA Netw Open 7(7):e2421665. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.21665","journal-title":"JAMA Netw Open"},{"issue":"2","key":"9089_CR80","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5021\/ad.24.159","volume":"37","author":"HS Han","year":"2025","unstructured":"Han HS, Seok J, Park KY (2025) Air pollution and skin diseases. Ann Dermatol 37(2):53\u201367. https:\/\/doi.org\/10.5021\/ad.24.159","journal-title":"Ann Dermatol"},{"issue":"2","key":"9089_CR81","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1002\/ski2.104","volume":"2","author":"M Green","year":"2022","unstructured":"Green M, Kashetsky N, Feschuk A, Maibach HI (2022) Transepidermal water loss (TEWL): environment and pollution a systematic review. Skin Health Dis 2(2):e104. https:\/\/doi.org\/10.1002\/ski2.104","journal-title":"Skin Health Dis"},{"key":"9089_CR82","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2147\/CCID.S312556","volume":"14","author":"X Zheng","year":"2021","unstructured":"Zheng X, Wang Q, Luo Y et al (2021) Seasonal variation of psoriasis and its impact in the therapeutic management: a retrospective study on Chinese patients. Clin Cosmet Investig Dermatol 459\u2013465. https:\/\/doi.org\/10.2147\/CCID.S312556","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"9089_CR83","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/srt.13102","volume":"28","author":"KK Jensen","year":"2022","unstructured":"Jensen KK, Serup J, Alsing KK (2022) Psoriasis and seasonal variation: a systematic review on reports from Northern and Central Europe little overall variation but distinctive subsets with improvement in summer or wintertime. Skin Res Technol 28(1):180\u2013186. https:\/\/doi.org\/10.1111\/srt.13102","journal-title":"Skin Res Technol"},{"issue":"11","key":"9089_CR84","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/exd.14649","volume":"31","author":"A Luengas-Martinez","year":"2022","unstructured":"Luengas-Martinez A, Paus R, Iqbal M, Bailey L, Ray DW, Young HS (2022) Circadian rhythms in psoriasis and the potential of chronotherapy in psoriasis management. Exp Dermatol 31(11):1800\u20131809. https:\/\/doi.org\/10.1111\/exd.14649","journal-title":"Exp Dermatol"},{"key":"9089_CR85","doi-asserted-by":"publisher","first-page":"111993","DOI":"10.1016\/j.intimp.2024.111993","volume":"132","author":"X Yuan","year":"2024","unstructured":"Yuan X, Ou C, Li X, Zhuang Z, Chen Y (2024) The skin circadian clock gene F3 as a potential marker for psoriasis severity and its bidirectional relationship with IL-17 signaling in keratinocytes. Int Immunopharmacol 132:111993. https:\/\/doi.org\/10.1016\/j.intimp.2024.111993","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"9089_CR86","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jid.2017.10.001","volume":"138","author":"J Hirata","year":"2018","unstructured":"Hirata J, Hirota T, Ozeki T, Kanai M, Sudo T, Tanaka T, Hizawa N, Nakagawa H, Sato S, Mushiroda T, Saeki H, Tamari M, Okada Y (2018) Variants at HLA-A, HLA-C, and HLA-DQB1 confer risk of psoriasis vulgaris in Japanese. J Invest Dermatol 138(3):542\u2013548. https:\/\/doi.org\/10.1016\/j.jid.2017.10.001","journal-title":"J Invest Dermatol"},{"issue":"1","key":"9089_CR87","doi-asserted-by":"publisher","first-page":"100069","DOI":"10.1016\/j.xhgg.2021.100069","volume":"3","author":"PE Stuart","year":"2022","unstructured":"Stuart PE, Tsoi LC, Nair RP et al (2022) Transethnic analysis of psoriasis susceptibility in South Asians and Europeans enhances fine-mapping in the MHC and genomewide. HGG Adv 3(1):100069. https:\/\/doi.org\/10.1016\/j.xhgg.2021.100069","journal-title":"HGG Adv"},{"issue":"3","key":"9089_CR88","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41435-024-00271-w","volume":"25","author":"C Antonatos","year":"2024","unstructured":"Antonatos C, Georgakilas GK, Evangelou E, Vasilopoulos Y (2024) Transcriptomic meta-analysis characterizes molecular commonalities between psoriasis and obesity. Genes Immun 25(3):179\u2013187. https:\/\/doi.org\/10.1038\/s41435-024-00271-w","journal-title":"Genes Immun"},{"issue":"1","key":"9089_CR89","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1186\/s12967-024-05591-z","volume":"22","author":"F Orcales","year":"2024","unstructured":"Orcales F, Kumar S, Bui A, Johnson C, Liu J, Huang ZM, Liao W (2024) A partitioned polygenic risk score reveals distinct contributions to psoriasis clinical phenotypes across a multi-ethnic cohort. J Transl Med 22(1):835. https:\/\/doi.org\/10.1186\/s12967-024-05591-z","journal-title":"J Transl Med"},{"key":"9089_CR90","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s13671-024-00424-0","volume":"13","author":"S Singh","year":"2024","unstructured":"Singh S, Ramani P, Jayakumar ND et al (2024) Oral psoriasis an overlooked entity: current paradigms and future perspectives. Curr Derm Rep 13:85\u201394. https:\/\/doi.org\/10.1007\/s13671-024-00424-0","journal-title":"Curr Derm Rep"},{"issue":"6","key":"9089_CR91","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30(6):492\u2013506. https:\/\/doi.org\/10.1038\/s41422-020-0332-7","journal-title":"Cell Res"},{"key":"9089_CR92","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/bab.2669","volume":"72","author":"RK Sharma","year":"2025","unstructured":"Sharma RK, Sharma MR, Singh S, Mahendra A, Kumar A, Sharma SP et al (2025) Dysbiosis of pro-inflammatory and anti-inflammatory salivary cytokines during psoriasis providing a therapeutic window and a valuable diagnostic aid in future. Biotechnol Appl Biochem 72:369\u2013376. https:\/\/doi.org\/10.1002\/bab.2669","journal-title":"Biotechnol Appl Biochem"},{"issue":"1","key":"9089_CR93","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/jid.2008.194","volume":"129","author":"LC Zaba","year":"2009","unstructured":"Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC, Gonzalez J, Krueger JG, Lowes MA (2009) Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells. J Investig Dermatol 129(1):79\u201388. https:\/\/doi.org\/10.1038\/jid.2008.194","journal-title":"J Investig Dermatol"},{"issue":"3","key":"9089_CR94","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","volume":"180","author":"M Detmar","year":"1994","unstructured":"Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF (1994) Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180(3):1141\u20131146. https:\/\/doi.org\/10.1084\/jem.180.3.1141","journal-title":"J Exp Med"},{"issue":"1","key":"9089_CR95","doi-asserted-by":"publisher","first-page":"17134","DOI":"10.1038\/s41598-023-44346-6","volume":"13","author":"CC He","year":"2023","unstructured":"He CC, Song TC, Qi RQ, Gao XH (2023) Integrated single-cell and spatial transcriptomics reveals heterogeneity of fibroblast and pivotal genes in psoriasis. Sci Rep 13(1):17134. https:\/\/doi.org\/10.1038\/s41598-023-44346-6","journal-title":"Sci Rep"},{"key":"9089_CR96","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1038\/ncomms8001","volume":"6","author":"LC Tsoi","year":"2015","unstructured":"Tsoi LC, Spain SL, Ellinghaus E, Stuart PE, Capon F, Knight J, Tejasvi T, Kang HM, Allen MH, Lambert S, Stoll SW, Weidinger S, Gudjonsson JE, Koks S, Kingo K, Esko T, Das S, Metspalu A, Weichenthal M, Enerback C, Elder JT (2015) Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nat Commun 6:7001. https:\/\/doi.org\/10.1038\/ncomms8001","journal-title":"Nat Commun"},{"issue":"9","key":"9089_CR97","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen SL, Jain R, Garg AV, Cua DJ (2014) The IL-23\u2013IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 14(9):585\u2013600. https:\/\/doi.org\/10.1038\/nri3707","journal-title":"Nat Rev Immunol"},{"key":"9089_CR98","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.3389\/fimmu.2018.02746","volume":"9","author":"A Mylonas","year":"2018","unstructured":"Mylonas A, Conrad C (2018) Psoriasis: classical vs. paradoxical. The yin\u2013yang of TNF and type I interferon. Front Immunol 9:2746. https:\/\/doi.org\/10.3389\/fimmu.2018.02746","journal-title":"Front Immunol"},{"key":"9089_CR99","doi-asserted-by":"publisher","first-page":"941071","DOI":"10.3389\/fimmu.2022.941071","volume":"13","author":"M Kamata","year":"2022","unstructured":"Kamata M, Tada Y (2022) Dendritic cells and macrophages in the pathogenesis of psoriasis. Front Immunol 13:941071. https:\/\/doi.org\/10.3389\/fimmu.2022.941071","journal-title":"Front Immunol"},{"issue":"1","key":"9089_CR100","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1084\/jem.20030451","volume":"199","author":"E Lee","year":"2004","unstructured":"Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, Dhodapkar M, Krueger JG (2004) Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199(1):125\u2013130. https:\/\/doi.org\/10.1084\/jem.20030451","journal-title":"J Exp Med"},{"issue":"4","key":"9089_CR101","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/ijms21041275","volume":"21","author":"M Furue","year":"2020","unstructured":"Furue M, Furue K, Tsuji G, Nakahara T (2020) Interleukin-17A and keratinocytes in psoriasis. Int J Mol Sci 21(4):1275. https:\/\/doi.org\/10.3390\/ijms21041275","journal-title":"Int J Mol Sci"},{"issue":"11","key":"9089_CR102","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/exd.12487","volume":"23","author":"RR Keijsers","year":"2014","unstructured":"Keijsers RR, Joosten I, van Erp PE, Koenen HJ, van de Kerkhof PC (2014) Cellular sources of IL-17 in psoriasis: a paradigm shift? Exp Dermatol 23(11):799\u2013803. https:\/\/doi.org\/10.1111\/exd.12487","journal-title":"Exp Dermatol"},{"issue":"1","key":"9089_CR103","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo J, Zhang H, Lin W, Lu L, Su J, Chen X (2023) Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther 8(1):437. https:\/\/doi.org\/10.1038\/s41392-023-01655-6","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"9089_CR104","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jid.2015.11.025","volume":"136","author":"H Ray-Jones","year":"2016","unstructured":"Ray-Jones H, Eyre S, Barton A, Warren RB (2016) One SNP at a time: moving beyond GWAS in psoriasis. J Invest Dermatol 136(3):567\u2013573. https:\/\/doi.org\/10.1016\/j.jid.2015.11.025","journal-title":"J Invest Dermatol"},{"issue":"2","key":"9089_CR105","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/511051","volume":"80","author":"M Cargill","year":"2007","unstructured":"Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80(2):273\u2013290. https:\/\/doi.org\/10.1086\/511051","journal-title":"Am J Hum Genet"},{"issue":"10","key":"9089_CR106","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.3390\/ijms26104775","volume":"26","author":"P Pastras","year":"2025","unstructured":"Pastras P, Aggeletopoulou I, Papantoniou K, Triantos C (2025) Targeting the IL-23 receptor gene: a promising approach in inflammatory bowel disease treatment. Int J Mol Sci 26(10):4775. https:\/\/doi.org\/10.3390\/ijms26104775","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9089_CR107","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cyto.2013.04.013","volume":"63","author":"OM Popa","year":"2013","unstructured":"Popa OM, Kriegova E, Popa L, Schneiderova P, Dutescu MI, Bojinca M, Bara C, Petrek M (2013) Association study in Romanians confirms IL23A gene haplotype block rs2066808\/rs11171806 as conferring risk to psoriatic arthritis. Cytokine 63(1):67\u201373. https:\/\/doi.org\/10.1016\/j.cyto.2013.04.013","journal-title":"Cytokine"},{"key":"9089_CR108","doi-asserted-by":"publisher","first-page":"594735","DOI":"10.3389\/fimmu.2020.594735","volume":"11","author":"T Liu","year":"2020","unstructured":"Liu T, Li S, Ying S, Tang S, Ding Y, Li Y, Qiao J, Fang H (2020) The IL-23\/IL-17 pathway in inflammatory skin diseases: from bench to bedside. Front Immunol 11:594735. https:\/\/doi.org\/10.3389\/fimmu.2020.594735","journal-title":"Front Immunol"},{"issue":"3","key":"9089_CR109","doi-asserted-by":"publisher","first-page":"e12846","DOI":"10.1111\/sji.12846","volume":"91","author":"K Furue","year":"2020","unstructured":"Furue K, Ito T, Tsuji G, Nakahara T, Furue M (2020) The CCL20 and CCR6 axis in psoriasis. Scand J Immunol 91(3):e12846. https:\/\/doi.org\/10.1111\/sji.12846","journal-title":"Scand J Immunol"},{"issue":"5","key":"9089_CR110","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.clindermatol.2007.11.002","volume":"26","author":"YY Li","year":"2008","unstructured":"Li YY, Zollner TM, Sch\u00f6n MP (2008) Targeting leukocyte recruitment in the treatment of psoriasis. Clin Dermatol 26(5):527\u2013538. https:\/\/doi.org\/10.1016\/j.clindermatol.2007.11.002","journal-title":"Clin Dermatol"},{"issue":"12","key":"9089_CR111","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.4049\/jimmunol.164.12.6621","volume":"164","author":"B Homey","year":"2000","unstructured":"Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, Catron D, Buchanan ME, M\u00fcller A, deWaal MR, Deng G, Orozco R, Ruzicka T, Lehmann P, Lebecque S, Caux C, Zlotnik A (2000) Up-regulation of macrophage inflammatory protein-3 alpha\/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164(12):6621\u20136632. https:\/\/doi.org\/10.4049\/jimmunol.164.12.6621","journal-title":"J Immunol"},{"issue":"9","key":"9089_CR112","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/jid.2009.65","volume":"129","author":"EG Harper","year":"2009","unstructured":"Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, Skorcheva I, Purdy D, Fitch E, Iordanov M, Blauvelt A (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129(9):2175\u20132183. https:\/\/doi.org\/10.1038\/jid.2009.65","journal-title":"J Invest Dermatol"},{"issue":"3","key":"9089_CR113","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/24755303231159106","volume":"8","author":"ZR Shi","year":"2023","unstructured":"Shi ZR, Mabuchi T, Riutta SJ, Wu X, Peterson FC, Volkman BF, Hwang ST (2023) The chemokine, CCL20, and its receptor, CCR6, in the pathogenesis and treatment of psoriasis and psoriatic arthritis. J Psoriasis Psoriatic Arthritis 8(3):107\u2013117. https:\/\/doi.org\/10.1177\/24755303231159106","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"9089_CR114","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12950-024-00427-5","volume":"21","author":"YJ Li","year":"2024","unstructured":"Li YJ, Geng WL, Li CC et al (2024) Progress of CCL20-CCR6 in the airways: a promising new therapeutic target. J Inflamm 21:54. https:\/\/doi.org\/10.1186\/s12950-024-00427-5","journal-title":"J Inflamm"},{"issue":"2","key":"9089_CR115","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.immuni.2006.01.005","volume":"24","author":"M Le Borgne","year":"2006","unstructured":"Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N, Caux C, A\u00eft-Yahia S, Vicari A, Kaiserlian D, Dubois B (2006) Dendritic cells rapidly recruited into epithelial tissues via CCR6\/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24(2):191\u2013201. https:\/\/doi.org\/10.1016\/j.immuni.2006.01.005","journal-title":"Immunity"},{"issue":"4","key":"9089_CR116","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41419-020-2495-z","volume":"11","author":"JW Shin","year":"2020","unstructured":"Shin JW, Kwon MA, Hwang J, Lee SJ, Lee JH, Kim HJ, Lee KB, Lee SJ, Jeong EM, Chung JH, Kim IG (2020) Keratinocyte transglutaminase 2 promotes CCR6+ \u03b3\u03b4T-cell recruitment by upregulating CCL20 in psoriatic inflammation. Cell Death Dis 11(4):301. https:\/\/doi.org\/10.1038\/s41419-020-2495-z","journal-title":"Cell Death Dis"},{"key":"9089_CR117","doi-asserted-by":"publisher","first-page":"31119","DOI":"10.1038\/srep31119","volume":"6","author":"SC Hu","year":"2016","unstructured":"Hu SC, Yu HS, Yen FL, Lin CL, Chen GS, Lan CC (2016) Neutrophil extracellular trap formation is increased in psoriasis and induces human \u03b2-defensin-2 production in epidermal keratinocytes. Sci Rep 6:31119. https:\/\/doi.org\/10.1038\/srep31119","journal-title":"Sci Rep"},{"issue":"8","key":"9089_CR118","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/medicina57080743","volume":"57","author":"N Zdanowska","year":"2021","unstructured":"Zdanowska N, Kasprowicz-Furma\u0144czyk M, Placek W, Owczarczyk-Saczonek A (2021) The role of chemokines in psoriasis\u2014an overview. Medicina (Kaunas) 57(8):754. https:\/\/doi.org\/10.3390\/medicina57080743","journal-title":"Medicina (Kaunas)"},{"key":"9089_CR119","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, McSkane M, Baba H, Lenz HJ (2018) CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2014a target for novel cancer therapy. Cancer Treat Rev 63:40\u201347. https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.007","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"9089_CR120","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1365-2990.2010.01089.x","volume":"36","author":"M M\u00fcller","year":"2010","unstructured":"M\u00fcller M, Carter S, Hofer MJ, Campbell IL (2010) Review: the chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity\u2014a tale of conflict and conundrum. Neuropathol Appl Neurobiol 36(5):368\u2013387. https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01089.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"9089_CR121","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3899\/jrheum.2024-0396","volume":"51","author":"R Offenheim","year":"2024","unstructured":"Offenheim R, Cruz-Correa OF, Ganatra D, Gladman DD (2024) Candidate biomarkers for response to treatment in psoriatic disease. J Rheumatol 51(12):1176\u20131186. https:\/\/doi.org\/10.3899\/jrheum.2024-0396","journal-title":"J Rheumatol"},{"issue":"2","key":"9089_CR122","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/ijms26020792","volume":"26","author":"NJ Macho\u0144","year":"2025","unstructured":"Macho\u0144 NJ, Zdanowska N, Klimek-Trojan P, Owczarczyk-Saczonek A (2025) Vascular cell adhesion molecule 1 and E-selectin as potential cardiovascular risk biomarkers in psoriasis. Int J Mol Sci 26(2):792. https:\/\/doi.org\/10.3390\/ijms26020792","journal-title":"Int J Mol Sci"},{"key":"9089_CR123","doi-asserted-by":"publisher","first-page":"110308","DOI":"10.1016\/j.clim.2024.110308","volume":"266","author":"R Li","year":"2024","unstructured":"Li R, Xiong Y, Ma L, Peng C, Qi S, Gao R, Wang P, Li F, Li J, Li Q, Chen A (2024) Neutrophil extracellular traps promote macrophage inflammation in psoriasis. Clinical immunology (Orlando, Fla.) 266:110308. https:\/\/doi.org\/10.1016\/j.clim.2024.110308","journal-title":"Clinical immunology (Orlando, Fla.)"},{"key":"9089_CR124","doi-asserted-by":"publisher","first-page":"652191","DOI":"10.3389\/fimmu.2021.652191","volume":"12","author":"GE Ryan","year":"2021","unstructured":"Ryan GE, Harris JE, Richmond JM (2021) Resident memory T cells in autoimmune skin diseases. Front Immunol 12:652191. https:\/\/doi.org\/10.3389\/fimmu.2021.652191","journal-title":"Front Immunol"},{"key":"9089_CR125","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"9089_CR126","doi-asserted-by":"publisher","first-page":"112185","DOI":"10.1016\/j.celrep.2023.112185","volume":"42","author":"L Zhang","year":"2023","unstructured":"Zhang L, Wei X, Wang Z, Liu P, Hou Y, Xu Y, Su H, Koci MD, Yin H, Zhang C (2023) NF-\u03baB activation enhances STING signaling by altering microtubule-mediated STING trafficking. Cell Rep 42(3):112185. https:\/\/doi.org\/10.1016\/j.celrep.2023.112185","journal-title":"Cell Rep"},{"issue":"6","key":"9089_CR127","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.4049\/jimmunol.1402608","volume":"194","author":"Y Grinberg-Bleyer","year":"2015","unstructured":"Grinberg-Bleyer Y, Dainichi T, Oh H, Heise N, Klein U, Schmid RM, Hayden MS, Ghosh S (2015) Cutting edge: NF-\u03baB p65 and c-Rel control epidermal development and immune homeostasis in the skin. J Immunol 194(6):2472\u20132476. https:\/\/doi.org\/10.4049\/jimmunol.1402608","journal-title":"J Immunol"},{"issue":"1","key":"9089_CR128","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/ijms25010167","volume":"25","author":"MJ Shin","year":"2024","unstructured":"Shin MJ, Kim HS, Lee P, Yang NG, Kim JY, Eun YS, Lee W, Kim D, Lee Y, Jung KE et al (2024) Mechanistic investigation of WWOX function in NF-\u03baB-induced skin inflammation in psoriasis. Int J Mol Sci 25(1):167. https:\/\/doi.org\/10.3390\/ijms25010167","journal-title":"Int J Mol Sci"},{"issue":"5","key":"9089_CR129","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.ymthe.2024.04.012","volume":"32","author":"T Neuwirth","year":"2024","unstructured":"Neuwirth T, Stary G (2024) Expanding strategies to resolve psoriasis-like inflammation: non-canonical NF-\u03baB signaling controls IL-23 production in dendritic cells. Mol Ther 32(5):1195\u20131196. https:\/\/doi.org\/10.1016\/j.ymthe.2024.04.012","journal-title":"Mol Ther"},{"key":"9089_CR130","doi-asserted-by":"publisher","first-page":"886127","DOI":"10.3389\/fimmu.2022.886127","volume":"13","author":"C Kizilirmak","year":"2022","unstructured":"Kizilirmak C, Bianchi ME, Zambrano S (2022) Insights on the NF-\u03baB system using live cell imaging: recent developments and future perspectives. Front Immunol 13:886127. https:\/\/doi.org\/10.3389\/fimmu.2022.886127","journal-title":"Front Immunol"},{"issue":"1","key":"9089_CR131","doi-asserted-by":"publisher","first-page":"20149","DOI":"10.1038\/s41598-020-76864-y","volume":"10","author":"S Watanabe","year":"2020","unstructured":"Watanabe S, Iwata Y, Fukushima H, Saito K, Tanaka Y, Hasegawa Y, Akiyama M, Sugiura K (2020) Neutrophil extracellular traps are induced in a psoriasis model of interleukin-36 receptor antagonist-deficient mice. Sci Rep 10(1):20149. https:\/\/doi.org\/10.1038\/s41598-020-76864-y","journal-title":"Sci Rep"},{"key":"9089_CR132","doi-asserted-by":"publisher","first-page":"1374934","DOI":"10.3389\/fimmu.2024.1374934","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Feng Y, Shi D (2024) NETosis of psoriasis: a critical step in amplifying the inflammatory response. Front Immunol 15:1374934. https:\/\/doi.org\/10.3389\/fimmu.2024.1374934","journal-title":"Front Immunol"},{"issue":"5","key":"9089_CR133","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3892\/ijmm.2024.5415","volume":"54","author":"L Chen","year":"2024","unstructured":"Chen L, Liu C, Xiang X, Qiu W, Guo K (2024) MiR-155 promotes an inflammatory response in HaCaT cells via the IRF2BP2\/KLF2\/NF-\u03baB pathway in psoriasis. Int J Mol Med 54(5):91. https:\/\/doi.org\/10.3892\/ijmm.2024.5415","journal-title":"Int J Mol Med"},{"key":"9089_CR134","doi-asserted-by":"publisher","first-page":"205873842093374","DOI":"10.1177\/2058738420933742","volume":"34","author":"M El-Komy","year":"2020","unstructured":"El-Komy M, Amin I, El-Hawary MS, Saadi D, Shaker O (2020) Upregulation of the miRNA-155, miRNA-210, and miRNA-20b in psoriasis patients and their relation to IL-17. Int J Immunopathol Pharmacol 34:2058738420933742. https:\/\/doi.org\/10.1177\/2058738420933742","journal-title":"Int J Immunopathol Pharmacol"},{"key":"9089_CR135","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M et al (2021) The JAK\/STAT signaling pathway: from bench to clinic. Sig Transduct Target Ther 6:402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"9089_CR136","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/ijms19010171","volume":"19","author":"E Calautti","year":"2018","unstructured":"Calautti E, Avalle L, Poli V (2018) Psoriasis: a STAT3-centric view. Int J Mol Sci 19(1):171. https:\/\/doi.org\/10.3390\/ijms19010171","journal-title":"Int J Mol Sci"},{"issue":"9","key":"9089_CR137","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.3390\/ijms25094681","volume":"25","author":"AR Furtunescu","year":"2024","unstructured":"Furtunescu AR, Georgescu SR, Tampa M, Matei C (2024) Inhibition of the JAK-STAT pathway in the treatment of psoriasis: a review of the literature. Int J Mol Sci 25(9):4681. https:\/\/doi.org\/10.3390\/ijms25094681","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9089_CR138","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1038\/s41467-023-39020-4","volume":"14","author":"F Ma","year":"2023","unstructured":"Ma F, Plazyo O, Billi AC, Tsoi LC, Xing X, Wasikowski R, Gharaee-Kermani M, Hile G, Jiang Y, Harms PW, Xing E, Kirma J, Xi J, Hsu JE, Sarkar MK, Chung Y, Di Domizio J, Gilliet M, Ward NL, Maverakis E, Klechevsky E, Voorhees JJ, Elder JT, Lee JH, Kahlenberg JM, Pellegrini M, Modlin RL, Gudjonsson JE (2023) Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis. Nat Commun 14(1):3455. https:\/\/doi.org\/10.1038\/s41467-023-39020-4","journal-title":"Nat Commun"},{"issue":"3","key":"9089_CR139","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jaci.2023.05.012","volume":"152","author":"J Kim","year":"2023","unstructured":"Kim J, Lee J, Li X, Lee HS, Kim K, Chaparala V, Murphy W, Zhou W, Cao J, Lowes MA, Krueger JG (2023) Single-cell transcriptomics suggest distinct upstream drivers of IL-17A\/F in hidradenitis versus psoriasis. J Allergy Clin Immunol 152(3):656\u2013666. https:\/\/doi.org\/10.1016\/j.jaci.2023.05.012","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"9089_CR140","doi-asserted-by":"publisher","first-page":"6778","DOI":"10.3390\/ijms25126778","volume":"25","author":"K Joo","year":"2024","unstructured":"Joo K, Karsulovic C, Sore M, Hojman L (2024) Pivotal role of mTOR in non-skin manifestations of psoriasis. Int J Mol Sci 25(12):6778. https:\/\/doi.org\/10.3390\/ijms25126778","journal-title":"Int J Mol Sci"},{"key":"9089_CR141","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/exd.14332","volume":"30","author":"C Zeng","year":"2021","unstructured":"Zeng C, Tsoi LC, Gudjonsson JE (2021) Dysregulated epigenetic modifications in psoriasis. Exp Dermatol 30:1156\u20131166. https:\/\/doi.org\/10.1111\/exd.14332","journal-title":"Exp Dermatol"},{"issue":"6","key":"9089_CR142","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20(6):1475. https:\/\/doi.org\/10.3390\/ijms20061475","journal-title":"Int J Mol Sci"},{"key":"9089_CR143","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM, Global Psoriasis Atlas (2020) National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 369:m1590. https:\/\/doi.org\/10.1136\/bmj.m1590","journal-title":"BMJ"},{"key":"9089_CR144","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12964-023-01381-0","volume":"22","author":"S Liu","year":"2024","unstructured":"Liu S, He M, Jiang J et al (2024) Triggers for the onset and recurrence of psoriasis: a review and update. Cell Commun Signal 22:108. https:\/\/doi.org\/10.1186\/s12964-023-01381-0","journal-title":"Cell Commun Signal"},{"issue":"6","key":"9089_CR145","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes JE, Yan BY, Chan TC, Krueger JG (2018) Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J Immunol 201(6):1605\u20131613. https:\/\/doi.org\/10.4049\/jimmunol.1800013","journal-title":"J Immunol"},{"key":"9089_CR146","doi-asserted-by":"publisher","unstructured":"Douroudis K, Ramessur R, Barbosa IA, Baudry D, Duckworth M, Angit C, Capon F, Chung R, Curtis CJ, Di Meglio P, Goulding JMR, Griffiths CEM, Lee SH, Mahil SK, Parslew R, Reynolds NJ, Shipman AR, Warren RB, Yiu ZZN, Simpson MA; BSTOP Study Groups (2022) Differences in clinical features and comorbid burden between HLA-C*06:02 carrier groups in >9,000 people with psoriasis. J Investig Dermatol 142(6):1617\u20131628.e10. https:\/\/doi.org\/10.1016\/j.jid.2021.08.446","DOI":"10.1016\/j.jid.2021.08.446"},{"key":"9089_CR147","doi-asserted-by":"publisher","unstructured":"Balan R, Grigora\u015f A, Popovici D, Am\u0103linei C (2021) The histopathological landscape of the major psoriasiform dermatoses. Arch Clin Cases 6(3):59\u201368. https:\/\/doi.org\/10.22551\/2019.24.0603.10155","DOI":"10.22551\/2019.24.0603.10155"},{"key":"9089_CR148","doi-asserted-by":"publisher","first-page":"2023\u20138\u20132","DOI":"10.7573\/dic.2023-8-2","volume":"12","author":"AK Leung","year":"2023","unstructured":"Leung AK, Barankin B, Lam JM, Leong KF (2023) Childhood guttate psoriasis: an updated review. Drugs Context 12:2023\u20138\u20132. https:\/\/doi.org\/10.7573\/dic.2023-8-2","journal-title":"Drugs Context"},{"key":"9089_CR149","unstructured":"Saleh D, Tanner LS (2025) Guttate psoriasis. In: StatPearls [Internet]. StatPearls Publishing,\u00a0Treasure Island (FL). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482498\/"},{"issue":"23","key":"9089_CR150","doi-asserted-by":"publisher","first-page":"12793","DOI":"10.3390\/ijms222312793","volume":"22","author":"R Singh","year":"2021","unstructured":"Singh R, Koppu S, Perche PO, Feldman SR (2021) The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications. Int J Mol Sci 22(23):12793. https:\/\/doi.org\/10.3390\/ijms222312793","journal-title":"Int J Mol Sci"},{"issue":"6","key":"9089_CR151","doi-asserted-by":"publisher","first-page":"738","DOI":"10.5021\/ad.2015.27.6.738","volume":"27","author":"NK Roh","year":"2015","unstructured":"Roh NK, Han SH, Youn HJ, Kim YR, Lee YW, Choe YB, Ahn KJ (2015) Tissue and serum inflammatory cytokine levels in Korean psoriasis patients: a comparison between plaque and guttate psoriasis. Ann Dermatol 27(6):738\u2013743. https:\/\/doi.org\/10.5021\/ad.2015.27.6.738","journal-title":"Ann Dermatol"},{"key":"9089_CR152","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s40496-022-00320-1","volume":"9","author":"S Singh","year":"2022","unstructured":"Singh S, Ramani P, Jayakumar ND et al (2022) Role of pro-inflammatory and anti-inflammatory cytokines in pathophysiology of psoriasis. Curr Oral Health Rep 9:132\u2013145. https:\/\/doi.org\/10.1007\/s40496-022-00320-1","journal-title":"Curr Oral Health Rep"},{"key":"9089_CR153","doi-asserted-by":"publisher","unstructured":"De Jes\u00fas-Gil C, Sans-de San Nicol\u00e1s L, Ruiz-Romeu E, Ferran M, Soria-Martinez L, Chiriac A, Celada A, Pujol RM, Santamaria-Bab\u00ed LF (2020) Specific IgA and CLA+ T-cell IL-17 response to Streptococcus pyogenes in psoriasis. J Investig Dermatol 140(7):1364\u20131370.e1. https:\/\/doi.org\/10.1016\/j.jid.2019.12.022","DOI":"10.1016\/j.jid.2019.12.022"},{"key":"9089_CR154","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2147\/CCID.S189000","volume":"12","author":"G Micali","year":"2019","unstructured":"Micali G, Verz\u00ec AE, Giuffrida G, Panebianco E, Musumeci ML, Lacarrubba F (2019) Inverse psoriasis: from diagnosis to current treatment options. Clin Cosmet Investig Dermatol 12:953\u2013959. https:\/\/doi.org\/10.2147\/CCID.S189000","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"9089_CR155","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/cup.14142","volume":"49","author":"M Knabel","year":"2022","unstructured":"Knabel M, Mudaliar K (2022) Histopathologic features of inverse psoriasis. J Cutan Pathol 49(3):246\u2013251. https:\/\/doi.org\/10.1111\/cup.14142","journal-title":"J Cutan Pathol"},{"issue":"3","key":"9089_CR156","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s13555-021-00536-6","volume":"11","author":"JJ Hong","year":"2021","unstructured":"Hong JJ, Mosca ML, Hadeler EK, Brownstone ND, Bhutani T, Liao WJ (2021) Genital and inverse\/intertriginous psoriasis: an updated review of therapies and recommendations for practical management. Dermatol Ther (Heidelb) 11(3):833\u2013844. https:\/\/doi.org\/10.1007\/s13555-021-00536-6","journal-title":"Dermatol Ther (Heidelb)"},{"key":"9089_CR157","doi-asserted-by":"publisher","unstructured":"Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 60(4):643\u2013659. https:\/\/doi.org\/10.1016\/j.jaad.2008.12.032","DOI":"10.1016\/j.jaad.2008.12.032"},{"issue":"12","key":"9089_CR158","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/ijd.17252","volume":"63","author":"L Mastorino","year":"2024","unstructured":"Mastorino L, Dapavo P, Macagno N, Ortoncelli M, Verrone A, Stroppiana E, Cariti C, Susca S, Siliquini N, di Corteranzo IG, Quaglino P, Ribero S (2024) Clinical characteristics and response to biological therapies for inverse psoriasis: a real-life comparison between the therapeutic effects of anti-IL-23 and anti-IL-17 agents. Int J Dermatol 63(12):1735\u20131739. https:\/\/doi.org\/10.1111\/ijd.17252","journal-title":"Int J Dermatol"},{"issue":"3","key":"9089_CR159","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s13555-022-00881-0","volume":"13","author":"R Rivera-D\u00edaz","year":"2023","unstructured":"Rivera-D\u00edaz R, Daud\u00e9n E, Carrascosa JM, Cueva P, Puig L (2023) Generalized pustular psoriasis: a review on clinical characteristics, diagnosis, and treatment. Dermatol Ther (Heidelb) 13(3):673\u2013688. https:\/\/doi.org\/10.1007\/s13555-022-00881-0","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"45","key":"9089_CR160","doi-asserted-by":"publisher","first-page":"e23068","DOI":"10.1097\/MD.0000000000023068","volume":"99","author":"ZJ Liu","year":"2020","unstructured":"Liu ZJ, Tian YT, Shi BY, Zhou Y, Jia XS (2020) Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 99(45):e23068. https:\/\/doi.org\/10.1097\/MD.0000000000023068","journal-title":"Medicine (Baltimore)"},{"key":"9089_CR161","doi-asserted-by":"publisher","unstructured":"Assan F, Husson B, Hegazy S, Seneschal J, Aubin F, Mah\u00e9 E, Jullien D, Sbidian E, D\u2019Incan M, Conrad C, Brenaut E, Girard C, Richard MA, Bachelez H, Viguier M; Groupe de Recherche sur le Psoriasis de la Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie (2022) Palmoplantar Pustulosis and Acrodermatitis Continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort. J Eur Acad Dermatol Venereol 36(9):1578\u20131583. https:\/\/doi.org\/10.1111\/jdv.18127","DOI":"10.1111\/jdv.18127"},{"issue":"1","key":"9089_CR162","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40265-023-01988-0","volume":"84","author":"D Bernardo","year":"2024","unstructured":"Bernardo D, Tha\u00e7i D, Torres T (2024) Spesolimab for the treatment of generalized pustular psoriasis. Drugs 84(1):45\u201358. https:\/\/doi.org\/10.1007\/s40265-023-01988-0","journal-title":"Drugs"},{"issue":"3","key":"9089_CR163","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s13555-021-00521-z","volume":"11","author":"M Mosca","year":"2021","unstructured":"Mosca M, Hong J, Hadeler E, Brownstone N, Bhutani T, Liao W (2021) Scalp psoriasis: a literature review of effective therapies and updated recommendations for practical management. Dermatol Ther (Heidelb) 11(3):769\u2013797. https:\/\/doi.org\/10.1007\/s13555-021-00521-z","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5","key":"9089_CR164","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s40257-019-00447-5","volume":"20","author":"A Kelly","year":"2019","unstructured":"Kelly A, Ryan C (2019) Genital psoriasis: impact on quality of life and treatment options. Am J Clin Dermatol 20(5):639\u2013646. https:\/\/doi.org\/10.1007\/s40257-019-00447-5","journal-title":"Am J Clin Dermatol"},{"key":"9089_CR165","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/PTT.S126281","volume":"7","author":"E Haneke","year":"2017","unstructured":"Haneke E (2017) Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management. Psoriasis (Auckl) 7:51\u201363. https:\/\/doi.org\/10.2147\/PTT.S126281","journal-title":"Psoriasis (Auckl)"},{"issue":"6","key":"9089_CR166","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ad.2015.02.005","volume":"106","author":"I Raposo","year":"2015","unstructured":"Raposo I, Torres T (2015) Nail psoriasis as a predictor of the development of psoriatic arthritis. Actas Dermosifiliogr 106(6):452\u2013457. https:\/\/doi.org\/10.1016\/j.ad.2015.02.005","journal-title":"Actas Dermosifiliogr"},{"issue":"4","key":"9089_CR167","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4103\/ijd.ijd_570_22","volume":"67","author":"S Dhar","year":"2022","unstructured":"Dhar S, Srinivas SM (2022) Psoriasis in pediatric age group. Indian J Dermatol 67(4):374\u2013380. https:\/\/doi.org\/10.4103\/ijd.ijd_570_22","journal-title":"Indian J Dermatol"},{"issue":"SPL4","key":"9089_CR168","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.26452\/ijrps.v11iSPL4.4435","volume":"11","author":"J Fernando","year":"2020","unstructured":"Fernando J, Rajendran SN (2020) Evaluation of psoriasis area and severity index and its correlation with DLQI in evaluating various parameters in psoriasis \u2013 a hospital-based study. Int J Res Pharm Sci 11(SPL4):2149\u20132153","journal-title":"Int J Res Pharm Sci"},{"issue":"3","key":"9089_CR169","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/antib13030076","volume":"13","author":"F Ferrara","year":"2024","unstructured":"Ferrara F, Verduci C, Laconi E, Mangione A, Dondi C, Del Vecchio M, Carlevatti V, Zovi A, Capuozzo M, Langella R (2024) Therapeutic advances in psoriasis: from biologics to emerging oral small molecules. Antibodies 13(3):76. https:\/\/doi.org\/10.3390\/antib13030076","journal-title":"Antibodies"},{"issue":"5","key":"9089_CR170","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/2040622318759282","volume":"9","author":"TC Chan","year":"2018","unstructured":"Chan TC, Hawkes JE, Krueger JG (2018) Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment. Ther Adv Chronic Dis 9(5):111\u2013119. https:\/\/doi.org\/10.1177\/2040622318759282","journal-title":"Ther Adv Chronic Dis"},{"issue":"8","key":"9089_CR171","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1007\/s12325-023-02568-0","volume":"40","author":"A Blauvelt","year":"2023","unstructured":"Blauvelt A, Chiricozzi A, Ehst BD, Lebwohl MG (2023) Safety of IL-23 p19 inhibitors for the treatment of patients with moderate-to-severe plaque psoriasis: a narrative review. Adv Ther 40(8):3410\u20133433. https:\/\/doi.org\/10.1007\/s12325-023-02568-0","journal-title":"Adv Ther"},{"issue":"3","key":"9089_CR172","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s13555-017-0187-0","volume":"7","author":"M Nakamura","year":"2017","unstructured":"Nakamura M, Lee K, Jeon C, Sekhon S, Afifi L, Yan D, Lee K, Bhutani T (2017) Guselkumab for the treatment of psoriasis: a review of phase III trials. Dermatol Ther (Heidelb) 7(3):281\u2013292. https:\/\/doi.org\/10.1007\/s13555-017-0187-0","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"9089_CR173","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s13555-025-01342-0","volume":"15","author":"D Tha\u00e7i","year":"2025","unstructured":"Tha\u00e7i D, Ohtsuki M, Maul JT, Szegedi A, Luna PC, Lynde CW, Soliman AM, Wang H, Kaufmann C, Ashley DG, Madihlaba T, Rubant S, Papp KA (2025) Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis: interim analysis from the VALUE global prospective post-marketing observational study at 25 months. Dermatol Ther (Heidelb) 15(2):381\u2013394. https:\/\/doi.org\/10.1007\/s13555-025-01342-0","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"9089_CR174","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/annrheumdis-2017-212127","volume":"77","author":"S Glatt","year":"2018","unstructured":"Glatt S, Baeten D, Baker T, Griffiths M, Ionescu L, Lawson ADG, Maroof A, Oliver R, Popa S, Strimenopoulou F, Vajjah P, Watling MIL, Yeremenko N, Miossec P, Shaw S (2018) Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. Ann Rheum Dis 77(4):523\u2013532. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212127","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"9089_CR175","doi-asserted-by":"publisher","first-page":"e004464","DOI":"10.1136\/rmdopen-2024-004464","volume":"10","author":"ME Husni","year":"2024","unstructured":"Husni ME, Mease PJ, Merola JF, Tillett W, Goldammer N, Ink B, Coarse J, Lambert J, Taieb V, Gladman DD (2024) Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studies. RMD Open 10(3):e004464. https:\/\/doi.org\/10.1136\/rmdopen-2024-004464","journal-title":"RMD Open"},{"issue":"6","key":"9089_CR176","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1001\/jamadermatol.2019.0098","volume":"155","author":"LJ van Vugt","year":"2019","unstructured":"van Vugt LJ, van den Reek JMPA, Hannink G, Coenen MJH, de Jong EMGJ (2019) Association of HLA-C*06:02 status with differential response to ustekinumab in patients with psoriasis: a systematic review and meta-analysis. JAMA Dermatol 155(6):708\u2013715. https:\/\/doi.org\/10.1001\/jamadermatol.2019.0098","journal-title":"JAMA Dermatol"},{"issue":"8","key":"9089_CR177","doi-asserted-by":"publisher","first-page":"7329","DOI":"10.3390\/ijms24087329","volume":"24","author":"CY Wang","year":"2023","unstructured":"Wang CY, Wang CW, Chen CB, Chen WT, Chang YC, Hui RC, Chung WH (2023) Pharmacogenomics on the treatment response in patients with psoriasis: an updated review. Int J Mol Sci 24(8):7329. https:\/\/doi.org\/10.3390\/ijms24087329","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9089_CR178","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/tpj.2016.16","volume":"17","author":"E Mendrinou","year":"2017","unstructured":"Mendrinou E, Patsatsi A, Zafiriou E, Papadopoulou D, Aggelou L, Sarri C, Mamuris Z, Kyriakou A, Sotiriadis D, Roussaki-Schulze A, Sarafidou T, Vasilopoulos Y (2017) FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNF\u03b1 inhibitors. Pharmacogenomics J 17(3):237\u2013241. https:\/\/doi.org\/10.1038\/tpj.2016.16","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"9089_CR179","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s41927-022-00287-7","volume":"6","author":"S Sarabia","year":"2022","unstructured":"Sarabia S, Ranjith B, Koppikar S, Wijeratne DT (2022) Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis. BMC Rheumatol 6(1):71. https:\/\/doi.org\/10.1186\/s41927-022-00287-7","journal-title":"BMC Rheumatol"},{"issue":"3","key":"9089_CR180","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1365-2133.2012.11168.x","volume":"167","author":"KA Papp","year":"2012","unstructured":"Papp KA, Menter A, Strober B, Langley RG, Buonanno M, Wolk R, Gupta P, Krishnaswami S, Tan H, Harness JA (2012) Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a phase 2b randomized placebo-controlled dose-ranging study. Br J Dermatol 167(3):668\u2013677. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11168.x","journal-title":"Br J Dermatol"},{"issue":"4","key":"9089_CR181","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/24755303231201336","volume":"8","author":"P Kingston","year":"2023","unstructured":"Kingston P, Blauvelt A, Strober B, Armstrong AW (2023) Deucravacitinib: a novel TYK2 inhibitor for the treatment of moderate-to-severe psoriasis. J Psoriasis Psoriatic Arthritis 8(4):156\u2013165. https:\/\/doi.org\/10.1177\/24755303231201336","journal-title":"J Psoriasis Psoriatic Arthritis"},{"issue":"6","key":"9089_CR182","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s40257-022-00720-0","volume":"23","author":"AM L\u00e9","year":"2022","unstructured":"L\u00e9 AM, Puig L, Torres T (2022) Deucravacitinib for the treatment of psoriatic disease. Am J Clin Dermatol 23(6):813\u2013822. https:\/\/doi.org\/10.1007\/s40257-022-00720-0","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"9089_CR183","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/pharmaceutics16010111","volume":"16","author":"A Drakos","year":"2024","unstructured":"Drakos A, Torres T, Vender R (2024) Emerging oral therapies for the treatment of psoriasis: a review of pipeline agents. Pharmaceutics 16(1):111. https:\/\/doi.org\/10.3390\/pharmaceutics16010111","journal-title":"Pharmaceutics"},{"issue":"1","key":"9089_CR184","doi-asserted-by":"publisher","first-page":"e14934","DOI":"10.1111\/exd.14934","volume":"33","author":"CL Okorie","year":"2024","unstructured":"Okorie CL, Nayudu K, Nambudiri VE (2024) Cutaneous findings and treatments in deficiency of interleukin-36 receptor antagonist (DITRA): a review of the literature. Exp Dermatol 33(1):e14934. https:\/\/doi.org\/10.1111\/exd.14934","journal-title":"Exp Dermatol"},{"issue":"1","key":"9089_CR185","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1038\/s41598-019-45626-w","volume":"9","author":"V Todorovi\u0107","year":"2019","unstructured":"Todorovi\u0107 V, Su Z, Putman CB, Kakavas SJ, Salte KM, McDonald HA, Wetter JB, Paulsboe SE, Sun Q, Gerstein CE, Medina L, Sielaff B, Sadhukhan R, Stockmann H, Richardson PL, Qiu W, Argiriadi MA, Henry RF, Herold JM, Shotwell JB, McGaraughty SP, Honore P, Gopalakrishnan SM, Sun CC, Scott VE (2019) Small molecule IL-36\u03b3 antagonist as a novel therapeutic approach for plaque psoriasis. Sci Rep 9(1):9089. https:\/\/doi.org\/10.1038\/s41598-019-45626-w","journal-title":"Sci Rep"},{"issue":"5","key":"9089_CR186","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4103\/ijp.ijp_240_24","volume":"56","author":"SP Duvvuri","year":"2024","unstructured":"Duvvuri SP, Burri RG, Ch AM, Meduri KC, Damineni U (2024) Effectiveness and safety of spesolimab in treating generalized pustular psoriasis: a comparative analysis of randomized controlled trials. Indian J Pharmacol 56(5):365\u2013366. https:\/\/doi.org\/10.4103\/ijp.ijp_240_24","journal-title":"Indian J Pharmacol"},{"issue":"3","key":"9089_CR187","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4103\/ijd.ijd_421_23","volume":"68","author":"SS Ahmed","year":"2023","unstructured":"Ahmed SS, De A, Das S, Manchanda Y (2023) Biologics and biosimilars in psoriasis. Indian J Dermatol 68(3):282\u2013295. https:\/\/doi.org\/10.4103\/ijd.ijd_421_23","journal-title":"Indian J Dermatol"},{"key":"9089_CR188","doi-asserted-by":"publisher","first-page":"109248","DOI":"10.1016\/j.intimp.2022.109248","volume":"112","author":"C Yu","year":"2022","unstructured":"Yu C, Zhang F, Ding Y, Li Y, Zhao Y, Gu J, Guo S, Pan W, Jin H, Sun Q, Kang X, Yang Q, Jiang X, Song Z, Lu Q, Pang X, Kuang Y, Deng D, Li Y, Zhang C, Wang G (2022) A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis. Int Immunopharmacol 112:109248. https:\/\/doi.org\/10.1016\/j.intimp.2022.109248","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"9089_CR189","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s12325-021-01899-0","volume":"39","author":"L Cai","year":"2022","unstructured":"Cai L, Li L, Cheng H, Ding Y, Biao Z, Zhang S, Geng S, Liu Q, Fang H, Song Z, Lu Y, Li S, Guo Q, Tao J, He L, Gu J, Yang Q, Han X, Gao X, Deng D, Zhang J (2022) Efficacy and safety of HLX03, an adalimumab biosimilar, in patients with moderate-to-severe plaque psoriasis: a randomized, double-blind, phase III study. Adv Ther 39(1):583\u2013597. https:\/\/doi.org\/10.1007\/s12325-021-01899-0","journal-title":"Adv Ther"},{"issue":"4","key":"9089_CR190","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/biomedicines13040781","volume":"13","author":"Y Li","year":"2025","unstructured":"Li Y, Cheng Y, Cai Y, Duan Z, Xu H, Huang Y, Ma X, Xin X, Yin L (2025) Novel small-molecule treatment and emerging biological therapy for psoriasis. Biomedicines 13(4):781. https:\/\/doi.org\/10.3390\/biomedicines13040781","journal-title":"Biomedicines"},{"issue":"12","key":"9089_CR191","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1001\/jamadermatol.2024.3897","volume":"160","author":"JM Gelfand","year":"2024","unstructured":"Gelfand JM, Armstrong AW, Lim HW, Feldman SR, Johnson SM, Claiborne WCC, Kalb RE, Jakus J, Mangold AR, Flowers RH, Bhutani T, Durkin JR, Bagel J, Fretzin S, Sheehan MP, Krell J, Reeder M, Kaffenberger J, Kartono F, Takeshita J, Callis DK (2024) Home- vs office-based narrowband UV-B phototherapy for patients with psoriasis: the LITE randomized clinical trial. JAMA Dermatol 160(12):1320\u20131328. https:\/\/doi.org\/10.1001\/jamadermatol.2024.3897","journal-title":"JAMA Dermatol"},{"issue":"3","key":"9089_CR192","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.xjidi.2021.100094","volume":"2","author":"J Liu","year":"2021","unstructured":"Liu J, Chang HW, Grewal R, Cummins DD, Bui A, Beck KM, Sekhon S, Yan D, Huang ZM, Schmidt TH, Yang EJ, Sanchez IM, Nakamura M, Bhattarai S, Thibodeaux Q, Ahn R, Pauli M, Bhutani T, Rosenblum MD, Liao W (2021) Transcriptomic profiling of plaque psoriasis and cutaneous T-cell subsets during treatment with secukinumab. JID innovations\u202f: skin science from molecules to population health 2(3):100094. https:\/\/doi.org\/10.1016\/j.xjidi.2021.100094","journal-title":"JID innovations : skin science from molecules to population health"},{"issue":"8","key":"9089_CR193","first-page":"988","volume":"15","author":"M Chow","year":"2016","unstructured":"Chow M, Lai K, Ahn R, Gupta R, Arron S, Liao W (2016) Effect of adalimumab on gene expression profiles of psoriatic skin and blood. Journal of drugs in dermatology\u202f: JDD 15(8):988\u2013994","journal-title":"Journal of drugs in dermatology : JDD"},{"issue":"6","key":"9089_CR194","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jpha.2023.05.009","volume":"13","author":"J Zeng","year":"2023","unstructured":"Zeng J, Li M, Zhao Q, Chen M, Zhao L, Wei S, Yang H, Zhao Y, Wang A, Shen J, Du F, Chen Y, Deng S, Wang F, Zhang Z, Li Z, Wang T, Wang S, Xiao Z, Wu X (2023) Small molecule inhibitors of ROR\u03b3t for Th17 regulation in inflammatory and autoimmune diseases. J Pharm Anal 13(6):545\u2013562. https:\/\/doi.org\/10.1016\/j.jpha.2023.05.009","journal-title":"J Pharm Anal"},{"key":"9089_CR195","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3389\/fimmu.2018.01210","volume":"9","author":"L Tang","year":"2018","unstructured":"Tang L, Yang X, Liang Y, Xie H, Dai Z, Zheng G (2018) Transcription factor retinoid-related orphan receptor \u03b3t: a promising target for the treatment of psoriasis. Front Immunol 9:1210. https:\/\/doi.org\/10.3389\/fimmu.2018.01210","journal-title":"Front Immunol"},{"issue":"11","key":"9089_CR196","doi-asserted-by":"publisher","first-page":"114951","DOI":"10.1016\/j.celrep.2024.114951","volume":"43","author":"X Zhong","year":"2024","unstructured":"Zhong X, Wu H, Zhang W, Shi Y, Gwack Y, Xue HH, Sun Z (2024) Distinct ROR\u03b3t-dependent Th17 immune responses are required for autoimmune pathogenesis and protection against bacterial infection. Cell Rep 43(11):114951. https:\/\/doi.org\/10.1016\/j.celrep.2024.114951","journal-title":"Cell Rep"},{"key":"9089_CR197","doi-asserted-by":"publisher","first-page":"115603","DOI":"10.1016\/j.biopha.2023.115603","volume":"167","author":"J He","year":"2023","unstructured":"He J, Zhao M, Ma X, Li D, Kong J, Yang F (2023) The role and application of three IFN-related reactions in psoriasis. Biomed Pharmacother 167:115603. https:\/\/doi.org\/10.1016\/j.biopha.2023.115603","journal-title":"Biomed Pharmacother"},{"key":"9089_CR198","doi-asserted-by":"publisher","first-page":"101875","DOI":"10.1016\/j.mtbio.2025.101875","volume":"32","author":"R Chen","year":"2025","unstructured":"Chen R, Duan B, Li S, Zhu Y, Huang Z, Shen D, Ye Z, Yan Y, Qiu C, Guan H, Yao Y, Dong J, Wu F, Jiang X, Shi X, Kou L (2025) A triple-targeting \u201cnano-brake\u201d remodeling the impaired immune microenvironment in skin lesions for psoriasis treatment. Mater Today Bio 32:101875. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101875","journal-title":"Mater Today Bio"},{"issue":"9","key":"9089_CR199","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1517\/14728222.2010.504716","volume":"14","author":"MN Hedrick","year":"2010","unstructured":"Hedrick MN, Lonsdorf AS, Hwang ST, Farber JM (2010) Ccr6 as a possible therapeutic target in psoriasis. Expert Opin Ther Targets 14(9):911\u2013922. https:\/\/doi.org\/10.1517\/14728222.2010.504716","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"9089_CR200","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/exd.14502","volume":"31","author":"L Samuelov","year":"2022","unstructured":"Samuelov L, Bochner R, Magal L, Malovitski K, Sagiv N, Nousbeck J et al (2022) Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis. Exp Dermatol 31(4):567\u2013576","journal-title":"Exp Dermatol"},{"issue":"1","key":"9089_CR201","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41419-019-2212-y","volume":"11","author":"S Thatikonda","year":"2020","unstructured":"Thatikonda S, Pooladanda V, Sigalapalli DK, Godugu C (2020) Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation. Cell Death Dis 11(1):21","journal-title":"Cell Death Dis"},{"key":"9089_CR202","doi-asserted-by":"publisher","first-page":"100211","DOI":"10.1016\/j.jtauto.2023.100211","volume":"7","author":"J Lu","year":"2023","unstructured":"Lu J, Lu Y (2023) Paradoxical psoriasis: the flip side of idiopathic psoriasis or an autocephalous reversible drug reaction? J Transl Autoimmun 7:100211. https:\/\/doi.org\/10.1016\/j.jtauto.2023.100211","journal-title":"J Transl Autoimmun"},{"issue":"4","key":"9089_CR203","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/jpm11040293","volume":"11","author":"C Membrive Jim\u00e9nez","year":"2021","unstructured":"Membrive Jim\u00e9nez C, P\u00e9rez Ram\u00edrez C, S\u00e1nchez Mart\u00edn A, Vieira Maroun S, Arias Santiago SA, Ram\u00edrez Tortosa MDC, Jim\u00e9nez Morales A (2021) Influence of genetic polymorphisms on response to biologics in moderate-to-severe psoriasis. J Pers Med 11(4):293. https:\/\/doi.org\/10.3390\/jpm11040293","journal-title":"J Pers Med"},{"issue":"21","key":"9089_CR204","doi-asserted-by":"publisher","first-page":"7873","DOI":"10.3390\/ijms21217873","volume":"21","author":"A Bucalo","year":"2020","unstructured":"Bucalo A, Rega F, Zangrilli A, Silvestri V, Valentini V, Scafetta G, Marraffa F, Grassi S, Rogante E, Piccolo A, Cucchiara S, Viola F, Bianchi L, Ottini L, Richetta A (2020) Paradoxical psoriasis induced by anti-TNF\u03b1 treatment: evaluation of disease-specific clinical and genetic markers. Int J Mol Sci 21(21):7873. https:\/\/doi.org\/10.3390\/ijms21217873","journal-title":"Int J Mol Sci"},{"key":"9089_CR205","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/PTT.S519420","volume":"15","author":"M Ponikowska","year":"2025","unstructured":"Ponikowska M, Vellone E, Czapla M, Uchmanowicz I (2025) Challenges psoriasis and its impact on quality of life: challenges in treatment and management. Psoriasis (Auckl) 15:175\u2013183. https:\/\/doi.org\/10.2147\/PTT.S519420","journal-title":"Psoriasis (Auckl)"},{"key":"9089_CR206","doi-asserted-by":"publisher","first-page":"1308822","DOI":"10.3389\/fendo.2024.1308822","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Dong S, Ma Y, Mou Y (2024) Burden of psoriasis in young adults worldwide from the Global Burden of Disease Study 2019. Front Endocrinol (Lausanne) 15:1308822. https:\/\/doi.org\/10.3389\/fendo.2024.1308822","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"9089_CR207","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1111\/bjd.15610","volume":"177","author":"CEM Griffiths","year":"2017","unstructured":"Griffiths CEM, van der Walt JM, Ashcroft DM, Flohr C, Naldi L, Nijsten T, Augustin M (2017) The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol 177(1):e4\u2013e7. https:\/\/doi.org\/10.1111\/bjd.15610","journal-title":"Br J Dermatol"},{"key":"9089_CR208","doi-asserted-by":"publisher","unstructured":"Jin L, Yang J, Wan P, Cheng Y (2025) Incidence trends of pediatric psoriasis in 1990\u20132021: findings from the global burden of disease study 2021. Clin Exp Dermatol llaf050. https:\/\/doi.org\/10.1093\/ced\/llaf050","DOI":"10.1093\/ced\/llaf050"},{"issue":"4","key":"9089_CR209","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00403-024-02846-z","volume":"316","author":"K Wang","year":"2024","unstructured":"Wang K, Zhao Y, Cao X (2024) Global burden and future trends in psoriasis epidemiology: insights from the Global Burden of Disease Study 2019 and predictions to 2030. Arch Dermatol Res 316(4):114. https:\/\/doi.org\/10.1007\/s00403-024-02846-z","journal-title":"Arch Dermatol Res"},{"key":"9089_CR210","doi-asserted-by":"publisher","first-page":"108318","DOI":"10.1016\/j.clim.2019.108318","volume":"211","author":"J Pouw","year":"2020","unstructured":"Pouw J, Leijten E, Radstake T, Boes M (2020) Emerging molecular biomarkers for predicting therapy response in psoriatic arthritis: a review of literature. Clin Immunol 211:108318. https:\/\/doi.org\/10.1016\/j.clim.2019.108318","journal-title":"Clin Immunol"},{"issue":"6","key":"9089_CR211","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/1346-8138.15721","volume":"48","author":"W Sondermann","year":"2021","unstructured":"Sondermann W, Fiege O, K\u00f6rber A, Scherbaum N (2021) Psychological burden of psoriatic patients in a German University Hospital Dermatology Department. J Dermatol 48(6):794\u2013806. https:\/\/doi.org\/10.1111\/1346-8138.15721","journal-title":"J Dermatol"},{"issue":"12","key":"9089_CR212","doi-asserted-by":"publisher","first-page":"e52935","DOI":"10.1371\/journal.pone.0052935","volume":"7","author":"AW Armstrong","year":"2012","unstructured":"Armstrong AW, Schupp C, Wu J, Bebo B (2012) Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation Survey Data 2003\u20132011. PLoS One 7(12):e52935. https:\/\/doi.org\/10.1371\/journal.pone.0052935","journal-title":"PLoS One"},{"issue":"7","key":"9089_CR213","doi-asserted-by":"publisher","first-page":"e0305870","DOI":"10.1371\/journal.pone.0305870","volume":"19","author":"AM Affandi","year":"2024","unstructured":"Affandi AM, Thiruchelvam K (2024) Patient perspective on psoriasis: psychosocial burden of psoriasis and its management in Malaysia. PLoS One 19(7):e0305870. https:\/\/doi.org\/10.1371\/journal.pone.0305870","journal-title":"PLoS One"},{"issue":"4","key":"9089_CR214","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1159\/000528945","volume":"239","author":"AW Armstrong","year":"2023","unstructured":"Armstrong AW, Bohannan B, Mburu S, Coates LC, Ogdie A, Alarcon I, Kasparek T, Frade S, Barrio SF, Augustin M (2023) Patient perspectives on psoriatic disease burden: results from the global psoriasis and beyond survey. Dermatology 239(4):621\u2013634. https:\/\/doi.org\/10.1159\/000528945","journal-title":"Dermatology"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09089-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T17:55:52Z","timestamp":1757354152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09089-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":214,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9089"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09089-4","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"18 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}